Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsE | 0.0186 | 0.211 | 0.2798 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSB | 0.0228 | 0.3026 | 0.4002 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0286 | 0.4275 | 0.5726 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0228 | 0.3026 | 0.4037 |
Mycobacterium tuberculosis | Probable multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0304 | 0.4672 | 0.6282 |
Mycobacterium ulcerans | thioesterase TesA | 0.0245 | 0.3402 | 0.4545 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks7 | 0.0304 | 0.4672 | 0.6282 |
Onchocerca volvulus | Fatty acid synthase homolog | 0.0531 | 0.9599 | 1 |
Schistosoma mansoni | methyltransferase-related | 0.0089 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable thioesterase TesA | 0.0245 | 0.3402 | 0.4574 |
Brugia malayi | AMP-binding enzyme family protein | 0.0091 | 0.004 | 0.004 |
Mycobacterium tuberculosis | Probable fatty acid synthase Fas (fatty acid synthetase) | 0.0093 | 0.0082 | 0.0111 |
Mycobacterium tuberculosis | Polyketide synthase Pks2 | 0.0286 | 0.4271 | 0.5743 |
Loa Loa (eye worm) | hypothetical protein | 0.0486 | 0.8622 | 1 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0304 | 0.4672 | 0.6262 |
Giardia lamblia | Methyltransferase like 2 | 0.0089 | 0 | 0.5 |
Mycobacterium ulcerans | thioesterase | 0.0245 | 0.3402 | 0.4545 |
Brugia malayi | AMP-binding enzyme family protein | 0.0275 | 0.4047 | 0.4047 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsB | 0.0228 | 0.3026 | 0.4037 |
Mycobacterium ulcerans | polyketide synthase | 0.0304 | 0.4672 | 0.6262 |
Mycobacterium leprae | PROBABLE THIOESTERASE TESA | 0.0245 | 0.3402 | 0.4513 |
Mycobacterium tuberculosis | Probable membrane bound polyketide synthase Pks6 | 0.0431 | 0.7437 | 1 |
Loa Loa (eye worm) | fatty acid synthase | 0.0291 | 0.4382 | 0.4427 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks8 | 0.0232 | 0.311 | 0.4182 |
Brugia malayi | Beta-ketoacyl synthase, N-terminal domain containing protein | 0.0286 | 0.4275 | 0.4275 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0286 | 0.4275 | 0.5748 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0286 | 0.4275 | 0.5726 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks5 | 0.0286 | 0.4271 | 0.5743 |
Mycobacterium ulcerans | fatty acid synthase Fas | 0.0093 | 0.0082 | 0.0058 |
Leishmania major | hypothetical protein, conserved | 0.0089 | 0 | 0.5 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0286 | 0.4275 | 0.5748 |
Mycobacterium ulcerans | polyketide synthase Pks9 | 0.0186 | 0.211 | 0.2798 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0304 | 0.4672 | 1 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSE | 0.0186 | 0.211 | 0.2756 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0286 | 0.4275 | 0.5748 |
Mycobacterium tuberculosis | Polyketide synthase Pks12 | 0.0304 | 0.4672 | 0.6282 |
Loa Loa (eye worm) | hypothetical protein | 0.0156 | 0.1464 | 0.0591 |
Mycobacterium ulcerans | multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0304 | 0.4672 | 0.6262 |
Mycobacterium tuberculosis | Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) | 0.0275 | 0.4047 | 0.5442 |
Mycobacterium ulcerans | polyketide synthase | 0.0286 | 0.4275 | 0.5726 |
Mycobacterium tuberculosis | Polyketide synthetase MbtD (polyketide synthase) | 0.0091 | 0.004 | 0.0053 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0286 | 0.4275 | 0.5726 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.021 | 0.2625 | 0.392 |
Mycobacterium ulcerans | polyketide synthase Pks13 | 0.0431 | 0.7437 | 1 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0286 | 0.4275 | 0.5726 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSA | 0.0286 | 0.4275 | 0.5701 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSC | 0.0304 | 0.4672 | 0.6241 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSD | 0.0286 | 0.4275 | 0.5701 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks1 | 0.0212 | 0.2667 | 0.3586 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0089 | 0 | 0.5 |
Onchocerca volvulus | 0.0513 | 0.9202 | 0.9285 | |
Mycobacterium leprae | Probable polyketide synthase Pks1 | 0.0304 | 0.4672 | 0.6241 |
Toxoplasma gondii | beta-ketoacyl synthase, N-terminal domain-containing protein | 0.0191 | 0.2222 | 0.2721 |
Mycobacterium tuberculosis | Polyketide synthase Pks13 | 0.0431 | 0.7437 | 1 |
Mycobacterium leprae | Probable multifunctional mycocerosic acid synthase membrane associated enzyme Mas | 0.0304 | 0.4672 | 0.6241 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks9 | 0.0167 | 0.1709 | 0.2298 |
Mycobacterium leprae | Polyketide synthase Pks13 | 0.0431 | 0.7437 | 1 |
Mycobacterium tuberculosis | Polyketide synthetase MbtC (polyketide synthase) | 0.0092 | 0.008 | 0.0107 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks15 | 0.0119 | 0.0659 | 0.0887 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.0275 | 0.4047 | 0.3987 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 112.2018 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.